These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2133273)

  • 1. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
    Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
    J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of a piperidine phospholipid.
    Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW
    Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
    Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
    Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
    Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
    Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
    Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
    Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
    J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some antagonists of platelet activating factor are cytotoxic for human malignant cell lines.
    Danhauser-Riedl S; Felix SB; Houlihan WJ; Zafferani M; Steinhauser G; Oberberg D; Kalvelage H; Busch R; Rastetter J; Berdel WE
    Cancer Res; 1991 Jan; 51(1):43-8. PubMed ID: 1988103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
    Houlihan WJ; Lee ML; Munder PG; Nemecek GM; Handley DA; Winslow CM; Happy J; Jaeggi C
    Lipids; 1987 Nov; 22(11):884-90. PubMed ID: 2832680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR; Bittman R; Peters A; Mayhew E
    J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of the R- and S-enantiomers of RS-2-[[hydroxy[[2-[ (octadecyloxy)methyl]tetrahydrofuran-2-yl]methoxy]-phosphinyl]oxy]-N, N,N,-trimethylethylaminium hydroxide inner salt.
    Houlihan WJ; Prasad K; Underwood R; Repic O; Munder PG
    J Med Chem; 1996 Jan; 39(2):605-8. PubMed ID: 8558533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC; Wykle RL; Modest EJ; Daniel LW
    Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
    Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
    Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
    Zhou X; Lu X; Arthur G
    Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonates.
    Furno-de Winter A; Broquet C; Haelters JP; Massicot F; Sturtz G; Godfroid JJ
    J Lipid Mediat; 1991; 3(3):289-300. PubMed ID: 1773030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
    Kosano H; Takatani O
    Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
    Samadder P; Arthur G
    Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL.
    Kára J; Borovicka M; Liebl V; Smolíková J; Ubik K
    Neoplasma; 1986; 33(2):187-205. PubMed ID: 3713923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.